Question 1

What drug properties make a medication suitable for modified-release delivery?

Accepted Answer

Ideal drugs have low molecular weight, aqueous solubility above 0.1 mg/mL, and balanced lipophilicity for optimal absorption. Stability in the gastrointestinal tract is essential; unstable drugs like nitroglycerin require alternative routes. Dose size under 1 gram and predictable concentration-response relationships further determine suitability for modified-release formulations.

Question 2

How does drug half-life influence modified-release system design?

Accepted Answer

Drugs with elimination half-lives between 2 and 4 hours are ideal candidates for modified-release systems, as seen with propranolol. Drugs with very short half-lives require frequent dosing and may not be suitable. Half-life directly affects how often doses must be administered and whether sustained-release formulations can effectively maintain therapeutic levels.

Question 3

Why is the route of administration critical for modified-release drugs?

Accepted Answer

The route must align with drug properties and therapeutic goals. Oral delivery suits stable drugs with doses under 1000 mg, while transdermal drug delivery systems bypass first-pass metabolism for drugs like nitroglycerin. Intramuscular and parenteral drug delivery systems injectables implants and infusion devices support extended action and overcome absorption limitations.

Question 4

What role does therapeutic range play in modified-release drug design?

Accepted Answer

Drugs with a wide therapeutic range tolerate fluctuations in plasma concentration, while those with narrow therapeutic indices demand precise release control to prevent toxicity. Pharmacodynamic factors including dose size and the concentration-response relationship determine how strictly drug release must be controlled to maintain safety and efficacy.

Question 5

How do modified-release systems optimize drug absorption compared to conventional formulations?

Accepted Answer

In conventional dosage forms, absorption is the limiting step, but in modified-release systems, the rate of drug release from the formulation becomes the key determinant. This controlled release aligns with the drug's pharmacokinetic profile and therapeutic objective, ensuring consistent absorption and minimizing side effects while reducing required doses.

Question 6

Why is gastrointestinal stability important for oral modified-release drugs?

Accepted Answer

Drugs unstable in the gastrointestinal tract cannot maintain consistent absorption through oral delivery, compromising therapeutic effectiveness. Unstable drugs like nitroglycerin require alternative routes such as transdermal administration to ensure reliable drug delivery. Stability assessment is therefore essential before selecting the appropriate administration route.

Question 7

What is the relationship between drug lipophilicity and modified-release formulation success?

Accepted Answer

Lipophilic drugs with high partition coefficients exhibit enhanced absorption and tissue distribution, making them suitable for modified-release systems. Balanced lipophilicity—neither too hydrophilic nor too lipophilic—optimizes drug performance. This property influences both the formulation strategy and the route of administration selected for effective controlled delivery.

Modifiye Salımlı İlaç Taşıma Sistemleri: Etkileyen Faktörler

Browse More Videos